Answer
Lumykras (sotorasib) is contraindicated in patients with hypersensitivity to sotorasib or any excipient listed in section 6.1 of its SmPC.
Sources for this answer
- LUMYKRAS 240 mg film-coated tabletsAmgen Ltd · emc · SmPC §4.3 Contraindications · Version 3Document updated
Sources checked